Matrix Metalloproteinases (MMPs) as Novel Prognostic Biomarkers to Predict Disease Progression, Survival Duration, and Recurrence Rate in Oral Cancer Patients
- 16 January 2025
- journal article
- review article
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 16 (5) , 937-953
Abstract
Oral cancer is the most common subtype of head and neck cancer, occupying a large proportion of all cancer patients in India. Since it is a non-communicable disease, it does not spread from person to person. The root of oral cancer development lies in the risk factors responsible for the disease. Addiction to tobacco and alcohol are the primary risk factors, followed by genetic and environmental factors. The gold standard treatment option for oral cancer includes the surgical excision of the tumor following the flap reconstruction for functional rehabilitation. Apart from this, help of radiotherapy, chemotherapy, and immunotherapy could be taken depending upon the disease condition. When patients get affected with the disease and visit the hospital, the primary concern of patients involves the course of disease progression, survival duration after the treatment, and the chance of recurrence of the disease. Despite advancements in medical technology, it is still not possible to predict the progression of disease, survival duration, and recurrence rate in oral cancer. Matrix metalloproteinases (MMPs) are novel biomarkers belonging to the family of the proteinases and are known to be involved in the degradation of the extracellular matrix (ECM). MMPs could be good predictors of disease progression, survival duration, and recurrence rate as the molecular changes appear in the body before the physical changes. By predicting the disease progression, survival duration, and recurrence rate of patients, it will become easy to manage the disease and improve the quality of life of the patients. MMPs can facilitate the regular monitoring of patients for changes in the tumor microenvironment, which can help monitor metastasis. In this review, we highlighted the various types of MMPs and their role in oral cancer. We also aim to integrate all the MMP data into a single molecular pathway so that scattered data can be observed as a useful information tool for further research.Keywords
Funding Information
- Postgraduate Institute of Medical Education and Research, Chandigarh (A30011/Ph.D./1Trg/July2019)
This publication has 65 references indexed in Scilit:
- Accuracy of a self-reported Measure in Psychological Assessment when the Instrument is self-administered by the Patient or when Administrated by the ClinicianIndian Journal of Otolaryngology and Head & Neck Surgery, 2022
- Media Commercials Conveying Awareness Regarding Prevention of Head and Neck Cancer by Focusing on Stigmatized Perspective of Disease: Right or Wrong?Indian Journal of Otolaryngology and Head & Neck Surgery, 2021
- Stigmatic Impact of COVID-19 Pandemic on Head & Neck Cancers SurvivorsIndian Journal of Otolaryngology and Head & Neck Surgery, 2021
- Clinical yoga trial aim to improve quality of life at advanced stages of oral cancerSport Sciences for Health, 2021
- Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and ImplicationsCurrent Oncology Reports, 2019
- May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?Pathology and Oncology Research, 2016
- Studies on the expression of MMP-9 and significance of a macrophage assay in oral squamous cell carcinomaChinese Journal of Clinical Oncology, 2007
- Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancerHead & Neck, 2007
- Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expressionJournal of Surgical Oncology, 2006
- Matrix metalloproteases in head and neck cancerHead & Neck, 2006